Neuralstem secures patent for stem cell transplantation

09/9/2009 | American City Business Journals

Neuralstem has received a patent for the production and transplantation of neural stem cells for the treatment of nervous system disorders. The company is awaiting a decision from the FDA on its request to start human trials of its stem cell therapies for amyotrophic lateral sclerosis, or Lou Gehrig's disease.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health